Finance news

The Belmont University School of Pharmacy has launched of the school's first research study.

The project will investigate the stability of liquid forms of several drugs previously only available in solid dosage forms such as tablets, capsules.

The study is possible because of $157,000 contract grant with Galipot, the manufacturer of SyrSpend SF, the sugar-free syrup suspension agent for the drug's active ingredients.

The research project will involve Belmont pharmacy faculty members in evaluating 71 different drugs over the next two years.

Liquid forms of drugs are vital to the treatment of infants, children and patients whose illnesses prevent swallowing.

The process of testing the 71 drugs involves mixing the active ingredients into the liquid suspension agent.

"I'm excited that our first research project as a school will serve patients who are often most in need: young children and patients with cancer, stroke or other devastating conditions who have lost their ability to swallow," says Dr paydayloans.com. Phil Johnston, dean of the School of Pharmacy in a news release.

The school recently bought high-level equipment which enables the scientists to measure how much of the drug remains active in the solution over time.

It will seat its first class of 75 students in August.